Youtube Pro Stock Picks

Click here to search for stock quotes, financial statistics and more.

or

Analysts

HIVE stock
Analysts Crypto Trending hive
HIVE Digital Technologies is a buy, Roth Capital says

HIVE Digital Technologies (HIVE Digital Technologies Stock Quote, Chart, News, Analysts, Financials NASDAQ:HIVE) is rapidly scaling its Bitcoin mining operations, surpassing 8.3 EH/s and staying on track to hit 18 EH/s by late summer, an expansion fully funded through BTC-backed equipment deals. Roth Capital’s Darren Aftahi, who maintained his “Buy” rating and $6.00 target in […]

SYZ stock
Analysts syz
Paradigm Capital lowers price target on Sylogist

Paradigm Capital analyst Daniel Rosenberg lowered his target price on Sylogist (Sylogist Stock Quote, Chart, News, Analysts, Financials TSX:SYZ) to $12.75 from $13.00 in a May 15 research note, citing higher near-term costs from building out the company’s partner sales channel. However, he maintained a “Buy” rating, indicating strong SaaS momentum and improving operating leverage […]

AIDX
Share Tweet linked In Share

Get Stock Picks from the Pros.
In your Inbox.

After the market close on Thursday, Research in Motion (TSX:RIM) will announce its Q4 2012 and full ...

Oncolytics Biotech CEO Brad Thompson. Byron Capital analyst Douglas Loe has a $9 target on the company's stock.

Last month, Calgary’s Oncolytics Biotech (TSX:ONC) completed a bought deal financing, raising ...

Last November, approximately forty people were injured at Jakarta's Pacific Place Mall when rumours spread a store there was low on the supply of the new BlackBerry Bold.

Last November, approximately forty people were injured at Jakarta’s Pacific Place Mall when ru...

Byron Capital healthcare analyst Douglas Loe believes that allergy treatment Oralair could become a leading product in Paladin Labs' already diverse offering.

Paladin Labs (TSX:PLB) yesterday announced it has received approval from Health Canada for it grass ...

Inside a full scale model interior of a Bombardier CSeries. Byron Capital analyst Tom Astle says the company's commercial aircraft business has been a drag on overall valuation, but may be improved by it recent deal with the Commercial Aircraft Corporation of China.

Bombardier (TSX:BBD.B) today provided some detail on the agreement it signed with the government own...

Some surprising news from Cardiome (TSX:COM) today as the company announced that Merck will disconti...

In a research update Tuesday, Versant analyst Tom Liston says a management shakeup at Wireless Matrix probably came about because of

A shuffle at Wireless Matrix (TSX:WRX) this week as the company announced that J. Richard Carlson, w...

Think border lineups are bad now? Without Waterloo's Descartes Systems they'd be a whole lot worse.

Descartes Systems Group (TSX:DSG) yesterday reported its fiscal 2012 results. Revenue was up 15% fro...

Wi-LAN CEO Jim Skippen. Byron Capital analyst Tom Astle says new and current patent portfolio combined with current and upcoming litigation activity could drive Wi-LAN's revenue growth by 25% in 2013.

Wi-LAN (TSX:WIN) today reported its fiscal 2011 results. The company’s topline of $105.8-milli...

With a quarter-million users as of November 8th, more than three times the number the company expected, Transgaming's GameTreeTV is, after numerous delays, a hit.

Until now, the story of TransGaming (TSXV:TNG) has been one of incremental gains. The Toronto compan...

IMRIS CEO David Graves. On Friday, Byron Capital Healthcare Analyst Douglas Loe reiterated his BUY rating and $8 target on the stock.

On Thursday, IMRIS (TSX:IM) reported its Q4 and fiscal 2011 results. Across the board, the numbers w...

On Wednesday, Algonquin Power announced it had secured a twenty-five year Power Purchase agreement with Sask Power for a 177 megawatt wind power project, beating out twenty-seven other proposals.

On Wednesday, Algonquin Power (TSX:AQN) announced it had secured a twenty-five year Power Purchase a...

Byron Capital analyst Tom Astle says that while there are many caveats to be aware of with Bombardier and its balance sheet, there appears to be more upside than downside in its share price.

On the first day of December last year, Bombardier (TSX:BBD.B) reported its Q3, 2011 results. The Ca...

Dr. Yves Fradet, President of Diagnocure. On Wednesday, Byron Capital analyst Douglas Loe upgraded the company to Buy from Speculative Buy because he says Diagnocure is no longer as subject to clinical or regulatory risk.

This past Wednesday DiagnoCure (TSX:CUR), along with its US-based partner Gen-Probe, received FDA ap...

Dacryocytes, or teardrop-shaped cells, are found in myelofibrosis and myelophthisic states of bone marrow. Mississauga's YM Bioscience's Myelofibrosis treatment, CYT387, has performed well in Phase Two trials. Byron Capital Healthcare analyst Douglas Loe thinks this may soon attract a larger

Last Thursday, YM Biosciences (TSX:YM) reported its Q2, 2012 results. The company lost $6.55-million...

Open Text's Q2 signals the end of the John Shackleton era and the beginning of the Mark Barrenechea era. On January 2nd, the former President and CEO of Rackable took the helm at Waterloo's second most well known company.

On Wednesday, Waterloo’s Open Text (TSX:OTC) surprised the street with a particularly strong Q...

Byron Capital analyst Tom Astle says there are are similarities and important differences between Thorsten Heins at RIM and Mike Zafirovski's introduction as Nortel CEO in November of 2005.

This past Thursday, in the basement of a steakhouse in Toronto, new Research in Motion CEO Thorsten ...

AIDX
Share Tweet linked In Share

Get Stock Picks from the Pros. In your Inbox.

TRENDING

All Trending →
HIVE stock

HIVE Digital Technologies is a buy, Roth Capital says

 May 18, 2025

WELL Health is building a Canadian healthcare powerhouse, Beacon says

 May 15, 2025

WonderFi can do better than the Robinhood deal, Haywood says

 May 14, 2025
OGI stock

Buy Organigram for big returns, Haywood says

 May 13, 2025
DCBO stock

Docebo downgraded at ATB Capital

 May 12, 2025